FDA.reportPublic FDA data

1.91 ML Tezspire 110 MG/ML Auto-Injector

RxCUI
2628923
RxNorm name
1.91 ML Tezspire 110 MG/ML Auto-Injector
Display name
1.91 ML Tezspire 110 MG/ML Auto-Injector
Full name
1.91 ML Tezspire 110 MG/ML Auto-Injector
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:00

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761224Tezspiretezepelumab-ekko351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TEZSPIRETEZEPELUMAB-EKKOAmgen Inc60f0aa03-ad25-4d48-80ce-7fcfa76f325f2025-10-17Warnings, Adverse reactionsExact identifier
rxcui: 2628923

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
60f0aa03-ad25-4d48-80ce-7fcfa76f325f1.91 ML Tezspire 110 MG/ML Auto-InjectorSY15These highlights do not include all the information needed to use TEZSPIRE safely and effectively. See full prescribing information for TEZSPIRE. TEZSPIRE ® (tezepelumab-ekko) injection, for subcutaneous use Initial U.S. Approval: 202120251017
60f0aa03-ad25-4d48-80ce-7fcfa76f325fTezspire 210 MG in 1.91 ML Auto-InjectorPSN15These highlights do not include all the information needed to use TEZSPIRE safely and effectively. See full prescribing information for TEZSPIRE. TEZSPIRE ® (tezepelumab-ekko) injection, for subcutaneous use Initial U.S. Approval: 202120251017
60f0aa03-ad25-4d48-80ce-7fcfa76f325fTezspire 210 MG per 1.91 ML Auto-InjectorSY15These highlights do not include all the information needed to use TEZSPIRE safely and effectively. See full prescribing information for TEZSPIRE. TEZSPIRE ® (tezepelumab-ekko) injection, for subcutaneous use Initial U.S. Approval: 202120251017
60f0aa03-ad25-4d48-80ce-7fcfa76f325f1.91 ML tezepelumab-ekko 110 MG/ML Auto-Injector [Tezspire]SBD15These highlights do not include all the information needed to use TEZSPIRE safely and effectively. See full prescribing information for TEZSPIRE. TEZSPIRE ® (tezepelumab-ekko) injection, for subcutaneous use Initial U.S. Approval: 202120251017